Concepedia
Statistics
Publications
14
Citations
1.9K
H-Index
Active since
2001
Affiliations
KU Leuven(Current)
University of Bonn
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
VIB-KU Leuven Center for Cancer Biology
Antwerp University Hospital
Len Verbeke is an author at KU Leuven specializing in medicine, liver disease, and hepatology.
Publications per year
2001–2020
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations
Medicine, Internal Medicine, Pharmacotherapy +12
Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
Len Verbeke, Ricard Farré, Jonel Trebicka et al. · Hepatology · 2013 · 257 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
Len Verbeke, Inge Mannaerts, Robert Schierwagen et al. · Scientific Reports · 2016 · 229 citations · Full text
Medicine, Pathobiology, Pharmacology +17
The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
Len Verbeke, Ricard Farré, Bert Verbinnen et al. · American Journal Of Pathology · 2015 · 209 citations · Full text
Life Sciences, Biochemistry, Pharmacology +10
Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis
V. Cocquyt, Simon Van Belle, Robert Reinhardt et al. · European Journal of Cancer · 2001 · 148 citations
Medicine, Pharmacology, Pharmacotherapy +5
1–5 of 14